SCHEMBL9963577

SCHEMBL9963577

Cc1c2nc(NCC(=O)N3CCCCC3)sc2cc2sc(NCC(=O)N3CCC(N(C)C)CC3)nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.44
TP53 P04637 1/20 0.38
FABP4 P15090 1/20 0.38
RAB9A P51151 2/20 0.37
ALDH1A1 P00352 1/20 0.37
L3MBTL3 Q96JM7 2/20 0.35
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
GSK3B P49841 1/20 0.35
DYRK1A Q13627 1/20 0.35
NPC1 O15118 1/20 0.34
KDM1A O60341 2/20 0.34
MAOA P21397 2/20 0.34
MAOB P27338 2/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9963648 0.89 PTGS2 (0.40) PTGS2TP53FABP4RAB9AALDH1A1
SCHEMBL9963641 0.88 CHRM4 (0.35) PTGS2TP53FABP4LMNAGSK3B
SCHEMBL9963572 0.87 TP53 (0.51) PTGS2TP53RAB9AALDH1A1L3MBTL3
SCHEMBL9963574 0.86 PTGS2 (0.44) PTGS2TP53RAB9AALDH1A1LMNA
SCHEMBL9963545 0.85 PTGS2 (0.51) PTGS2TP53FABP4RAB9AALDH1A1
SCHEMBL9963583 0.85 PTGS2 (0.42) PTGS2TP53FABP4RAB9AALDH1A1
SCHEMBL9963539 0.85 PTGS2 (0.43) PTGS2FABP4RAB9AALDH1A1LMNA
SCHEMBL9963588 0.84 ACHE (0.46) PTGS2FABP4RAB9AALDH1A1
SCHEMBL9963553 0.84 PTGS2 (0.47) PTGS2TP53FABP4RAB9AALDH1A1
SCHEMBL9963695 0.84 PTGS2 (0.49) PTGS2FABP4RAB9AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032583-B1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-8203001-B2 Chemical compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-19 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
US-20090258857-A1 CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-10-15 US disclosed
WO-2007144370-A1 NEW CHEMICAL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258857-A1 CHEMICAL COMPOUNDS CCNA1, CCNT1, MKI67 PTGS2 2872/4885TP53 107/4885FABP4 1794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.